Reuters Logo

View in browser

Reuters Business

  Tweet       Share

Teva Pharm Q3 profit rises, sees higher 2023 revenue

Teva Pharmaceutical Industries reported slightly higher third-quarter profit, helped by sales of its Austedo treatment for Huntington's Disease, and said production in Israel was unaffected by the country's war with Hamas in Gaza.

US 30-year mortgage rate plunges by most in nearly 16 months - MBA

The interest rate on the most common type of U.S. residential mortgage plunged last week by the most in nearly 16 months on the back of a rally in the Treasury market that drove down the benchmark yields used to set home loan costs.

Take-Two surges on report widely awaited 'GTA VI' may be unveiled this week

Take-Two Interactive Software climbed 9% on Wednesday after a report the latest installment in its best-selling "Grand Theft Auto" videogame franchise could be announced as early as this week, likely ending fans' years-long wait.

Amazon cuts One Medical price again for Prime members

More than a year after Amazon.com agreed to buy One Medical, an in-person and virtual primary care practice, the company is cutting the telehealth service's price for a second time for Prime members.

'Barbie' success helps Warner Bros Discovery weather strike effects, weak ad market

Warner Bros Discovery topped third-quarter profit estimates on Wednesday as the box-office hit "Barbie" helped offset a sluggish advertising market and a studios segment starved of content due to two Hollywood strikes.

New York Times rides on ad market recovery to beat revenue expectations

New York Times surpassed revenue estimates for the third quarter on Wednesday as the advertising market picked up and more subscribers switched to its higher-priced bundles.

Biogen cuts annual profit forecast as higher costs persist

Biogen on Wednesday cut its annual profit forecast, which slipped below Wall Street expectations, due to rising costs from the recent acquisition of Reata Pharmaceuticals and the launch of its Alzheimer's treatment Leqembi.

Under Armour's robust margin forecast overshadows weak NA demand

Under Armour on Wednesday raised its annual gross margin expectations as the sportswear maker benefits from easing cost pressures and keeps a tight lid on expenses while struggling with tepid demand in its biggest market of North America.

Bayer says it is keeping strict line on settling glyphosate litigation

Bayer's finance chief said on Wednesday that the drugs and pesticides maker would remain very selective when considering any further settlements of U.S. litigation cases in which plaintiffs blame their cancer on Bayer's Roundup weedkiller.

Western miners seek premium pricing for rare earth metals to break China grip

A handful of Canadian, German and Australian critical mineral explorers plan to command premium prices for key metals used in electric vehicles, promising quality and consistency in exchange for shifting reliance away from China, the dominant producer and price-setter.

Sponsors are not involved in the creation of newsletters or other Reuters news content.

Advertise in this newsletter or on Reuters.com

To manage which newsletters you’re subscribed to, click here.
Want to stop receiving this email? Unsubscribe here.
facebook        twitter        instagram        youtube

© 2023 Thomson Reuters. All rights reserved.

3 Times Square, New York, NY 10036

Privacy Policy    |   Terms and Conditions